Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients
In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes:
- Beneficial effects beyond glycemic control
- Adverse events and how to manage them
- Non- or partial responders and the importance of setting expectations with patients
- Weight rebound when discontinuing therapy
- Medication access issues related to cost and drug availability
Presenters:
Jennifer Green, MD
Professor of Medicine
Division of Endocrinology and Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina
Carol Hatch Wysham, MD
Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington
Link to online program:
https://bit.ly/48b6XnW
